Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes

Journal of Periodontology

Volumn 83, Issue 4, 2012, Pages 426-434

  Duarte, Poliana Mendes ^a   Miranda, Tamires Szeremeske ^a   Lima, Jadson Almeida ^a   Goncxalves, Tiago Eduardo Dias ^a   Santos, Vanessa Renata ^a   Bastos, Marta Ferreira ^a   Ribeiro, Fernanda Vieira ^a  

^a GUARULHOS UNIVERSITY   (Brazil)

Author keywords

Chronic periodontitis; Cytokines; Diabetes mellitus; Gene expression; Polymerase chain reaction

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GAMMA INTERFERON; IFNG PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; FEMALE; GINGIVA; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADAPTIVE IMMUNITY; ADULT; BIOLOGICAL MARKERS; CHRONIC PERIODONTITIS; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GINGIVA; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; OSTEOPROTEGERIN; RANK LIGAND; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856606457     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110324     Document Type: Article

References (49)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27: 1047-1053. (Pubitemid 38579764)
2. Bruno G, Landi A. Epidemiology and costs of diabetes. Transplant Proc 2011;43:327-329.
3. Lim LP, Tay FB, Sum CF, Thai AC. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J Clin Periodontol 2007;34:118-123.
4. Chen L, Wei B, Li J, et al. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes. J Periodontol 2010;81:364-371.
5. Bandyopadhyay D, Marlow NM, Fernandes JK, Leite RS. Periodontal disease progression and glycaemic control among Gullah African Americans with type-2 diabetes. J Clin Periodontol 2010;37:501-509.
6. Southerland JH, Taylor GW, Offenbacher S. Diabetes and periodontal infection: Making the connection. Clin Diabetes 2005;23:171-178. (Pubitemid 41464518)
7. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ, et al. Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and Type 2 diabetes. J Periodontol 2004;75:1203-1208. (Pubitemid 39419718)
8. Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW. Expression of the receptor of advanced glycation end products in gingival tissues of Type 2 diabetes patients with chronic periodontal disease: A study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol 2005;32:40-44. (Pubitemid 40187424)
9. Engebretson SP, Vossughi F, Hey-Hadavi J, Emingil G, Grbic JT. The influence of diabetes on gingival crevicular fluid beta-glucuronidase and interleukin-8. J Clin Periodontol 2006;33:784-790. (Pubitemid 44511028)
10. Navarro-Sanchez AB, Faria-Almeida R, Bascones- Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in Type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 2007;34:835-843.
11. Duarte PM, de Oliveira MC, Tambeli CH, Parada CA, Casati MZ, Nociti FH Jr. Overexpression of interleukin- 1beta and interleukin-6 may play an important role in periodontal breakdown in Type 2 diabetic patients. J Periodontal Res 2007;42:377-381.
12. Cole CM, Sundararaj KP, Leite RS, et al. A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases. J Periodontal Res 2008;43:717-722.
13. Venza I, Visalli M, Cucinotta M, De Grazia G, Teti D, Venza M. Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without Type 2 diabetes. J Periodontol 2010;81:99-108.
14. Kardesxler L, Buduneli N, Cxetinkalp S, Lappin D, Kinane DF. Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes. Inflamm Res 2011;60:143-151.
15. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004;31:671-679. (Pubitemid 39092231)
16. Dutzan N, Gamonal J, Silva A, Sanz M, Vernal R. Overexpression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL)-17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis. J Clin Periodontol 2009;36:396-403.
17. Ohyama H, Kato-Kogoe N, Kuhara A, et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 2009;88:633-638.
18. Albiger B, Dahlberg S, Henriques-Normark B, Normark S. Role of the innate immune system in host defence against bacterial infections: Focus on the Toll-like receptors. J Intern Med 2007;261:511-528. (Pubitemid 46835986)
19. Bainbridge BW, Darveau RP. Porphyromonas gingivalis lipopolysaccharide: An unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol Scand 2001;59:131-138. (Pubitemid 33644361)
20. Ren L, Leung WK, Darveau RP, Jin L. The expression profile of lipopolysaccharide-binding protein, membranebound CD14, and toll-like receptors 2 and 4 in chronic periodontitis. J Periodontol 2005;76:1950-1959. (Pubitemid 41748985)
21. Sarah SM, Tamilselvan S, Kamatchiammal S, Suresh R. Expression of Toll-like receptors 2 and 4 in gingivitis and chronic periodontitis. Indian J Dent Res 2006;17: 114-116.
22. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
23. Fietta P, Delsante G. The effector T helper cell triade. Riv Biol 2009;102:61-74.
24. Cardoso CR, Garlet GP, Crippa GE, et al. Evidence of the presence of T helper Type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009;24:1-6.
25. Zhao L, Zhou Y, Xu Y, Sun Y, Li L, Chen W. Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients. J Clin Periodontol 2011;38:509-516.
26. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 2005;32:369-374. (Pubitemid 40569599)
27. Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005;32:383-389. (Pubitemid 40569601)
28. Tanaka S, Nakamura K, Takahasi N, Suda T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 2005;208:30-49. (Pubitemid 41746383)
29. Lu HK, Chen YL, Chang HC, Li CL, Kuo MY. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 2006;41:354-360. (Pubitemid 44392308)
30. Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J. Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol 2004;75:1586-1591. (Pubitemid 40260007)
31. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
32. Santos VR, Lima JA, Goncxalves TE, et al. Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. J Periodontol 2010;81:1455-1465.
33. Araujo MW, Hovey KM, Benedek JR, et al. Reproducibility of probing depth measurement using a constant-force electronic probe: Analysis of inter- and intraexaminer variability. J Periodontol 2003;74:1736-1740. (Pubitemid 38181214)
34. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-235.
35. Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010; 42:506-518.
36. Noronha AM, Liang Y, Hetzel JT, et al. Hyperactivated B cells in human inflammatory bowel disease. J Leukoc Biol 2009;86:1007-1016.
37. Jagannathan M, McDonnell M, Liang Y, et al. Tolllike receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010;53:1461-1471.
38. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441: 235-238.
39. Nakajima T, Ueki-Maruyama K, Oda T, et al. Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res 2005;84:639-643. (Pubitemid 43827846)
40. Cardoso CR, Garlet GP, Moreira AP, Jú nior WM, Rossi MA, Silva JS. Characterization of CD4+CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol 2008;84:311-318. (Pubitemid 351960306)
41. Bid HK, Konwar R, Agrawal CG, Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: A study in the north Indian population. Indian J Med Sci 2008;62:259-266.
42. Kazemi Arababadi M. Interleukin-4 gene polymorphisms in Type 2 diabetic patients with nephropathy. Iran J Kidney Dis 2010;4:302-306.
43. Shin DS, Park JW, Suh JY, Lee JM. The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with Type 2 diabetes mellitus. J Periodontal Implant Sci 2010;40:33-38.
44. Vieira Ribeiro F, de Mendoncxa AC, Santos VR, Bastos MF, Figueiredo LC, Duarte PM. Cytokines and bonerelated factors in systemically healthy patients with chronic periodontitis and patients with Type 2 diabetes and chronic periodontitis. J Periodontol 2011;82: 1187-1196.
45. Duarte PM, Santos VR, Dos Santos FA, de Lima Pereira SA, Rodrigues DB, Napimoga MH. Role of smoking and Type 2 diabetes in the immunobalance of advanced chronic periodontitis. J Periodontol 2011; 82:429-438.
46. Duarte PM, Neto JB, Casati MZ, Sallum EA, Nociti FH Jr. Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis. Oral Dis 2007;13:594-599. (Pubitemid 47609897)
47. Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ. RAGE: A multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 2010; 17:2232-2252.
48. Bierhaus A, Nawroth PP. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009;52:2251-2263.
49. Hollá LI, Kanková K, Fassmann A, et al. Distribution of the receptor for advanced glycation end products gene polymorphisms in patients with chronic periodontitis: A preliminary study. J Periodontol 2001;72:1742-1746. (Pubitemid 34092741)